Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
LITE Study Provides Encouraging Data on Home-Based Phototherapy for Psoriasis
Office-based phototherapy is not available in 90% of counties in the United States, “and a lack of US data has resulted in many insurance...
News
BTK Inhibitor Shows Promise for Hidradenitis Suppurativa
The novel drug is also under investigation in other immune-mediated inflammatory diseases, including chronic spontaneous urticaria and multiple...
News
Study Links Maternal Hidradenitis Suppurativa to Risk for Childhood Morbidity
The study population included 1283 children whose mothers had HS and 1,274,310 unexposed children.
News
Novel Agent Shows Promise for Hidradenitis Suppurativa
Longer-term phase 3 trials are planned to further examine the safety and efficacy of sonelokimab at the 120 mg dose.
News
Flexibility Recommended for Patients With Personality Disorders
"You want to recognize the personality disorder, understand that there are underlying conflicts and needs, and adjust accordingly," Mio Nakamura,...
News
Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?
Children with versus without atopic dermatitis were more likely to experience difficulties with learning and memory.
News
Another Neurotoxin for Frown Lines Enters the Market
FDA approved letibotulinumtoxinA-wlbg, which has been used in South Korea, to treat glabellar lines in adults.
News
Older Age Confers a Higher Risk for Second Primary Melanoma: Study
Knowledge about one's risk for a second primary invasive melanoma over time remains incomplete.
News
Study Evaluates Factors Driving Fatigue in Patients With Psoriasis, PsA
The study “highlights the importance of a symptom-based approach when treating psoriasis, ” the authors wrote.
News
Be Wary of TikTok Content on Infantile Hemangiomas: Study
Parents may turn to TikTok for information about IHs, but little is known about the quality of videos on the social media platform related to the...
News
Use of Biologics for Psoriasis Found to Confer a Survival Benefit
The study population consisted of 18,618 psoriasis cases and 55,854 controls.
News
Study Eyes Longer IV Ertapenem for Recalcitrant Hidradenitis Suppurativa
The mean treatment duration was 13.1 weeks and the mean posttherapy follow-up occurred after a mean of 7.8 weeks.
News
What Skin Manifestations Are Associated With Pediatric IBD?
The most common noninfectious dermatologic condition among the 425 children and adolescents was acne, followed by eczema.
News
Company Announces Regulatory Filing for Nemolizumab for Two Indications
The development comes on the heels of the phase III OLYMPIA trial program.
News
Tapinarof Cream Under FDA Review for Atopic Dermatitis Indication
The development is based on data from two phase 3 clinical trials and interim results from a long-term extension trial.